APA

Maeda A., Ando H., Asai T., Ishiguro H., Umemoto N., Ohta M., Morishima M., Sumida A., Kobayashi T., Hosohata K., Ushijima K. & Fujimura A. (20110228). Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. : Clinical pharmacology and therapeutics.

Chicago

Maeda A, Ando H, Asai T, Ishiguro H, Umemoto N, Ohta M, Morishima M, Sumida A, Kobayashi T, Hosohata K, Ushijima K and Fujimura A. 20110228. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. : Clinical pharmacology and therapeutics.

Harvard

Maeda A., Ando H., Asai T., Ishiguro H., Umemoto N., Ohta M., Morishima M., Sumida A., Kobayashi T., Hosohata K., Ushijima K. and Fujimura A. (20110228). Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. : Clinical pharmacology and therapeutics.

MLA

Maeda A, Ando H, Asai T, Ishiguro H, Umemoto N, Ohta M, Morishima M, Sumida A, Kobayashi T, Hosohata K, Ushijima K and Fujimura A. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. : Clinical pharmacology and therapeutics. 20110228.